Daiichi Sankyo

A→Z catalog of Daiichi Sankyo

A

• Amlodin / Amlodin OD — Amlodipine besylate — Hypertension, angina — 5–10 mg QD.

• Anplag — Sarpogrelate — Peripheral arterial disease — 100 mg TID.

• Aubagio (regional rights) — Teriflunomide — MS (co-promote).

B

• Benicar — Olmesartan medoxomil — Hypertension — 20–40 mg QD.

• Benicar HCT — Olmesartan + hydrochlorothiazide — Hypertension.

• Benicar Plus — Regional variant.

• BiCor — Bisoprolol fumarate — Hypertension, heart failure — 5–10 mg QD.

• BiCort (regional combo brands).

C

• Cilodan / Pletaal (Cilostan, Pletal) — Cilostazol — Intermittent claudication — 100 mg BID.

• Clair — Loratadine — Allergic rhinitis — 10 mg QD.

• Clotinab — Clopidogrel — Antiplatelet (regional).

• Colesevelam DS (Japan) — Colesevelam — Hyperlipidemia.

D

• Daiichisan (OTC line Japan, vitamins).

• Dualketo — Loxoprofen sodium + acetaminophen combo.

• Diquas — Diquafosol sodium ophthalmic solution 3% — Dry eye — 1 drop 6×/day.

• Dostarlimab co-promote (some regions).

E

• Effient / Efient — Prasugrel — ACS, stenting — 10 mg QD (5 mg elderly/low wt).

• Eclan — Eplerenone — Hypertension, heart failure — 25–50 mg QD.

• Edarbi — Azilsartan medoxomil — Hypertension — 40–80 mg QD.

• Edarbyclor — Azilsartan + chlorthalidone — Hypertension.

• Edoxaban (Lixiana / Savaysa) — Edoxaban tosilate — NVAF, DVT/PE — 30–60 mg QD.

• Esoral (regional generics line) — Esomeprazole.

F

• Famotidine Daiichi — Famotidine — GERD, ulcers — 20–40 mg daily.

• Fursemide Daiichi — Furosemide.

• Flivas — Naftopidil — BPH — 25–75 mg daily.

G

• Gaster — Famotidine — GERD, ulcers — 20 mg BID.

• Gaster D — Famotidine + domperidone (regional).

• Gaster-L — Famotidine + lansoprazole.

• Gaster tablets/IV forms.

H

• Hypertac / Hypertac Plus — Olmesartan-based brands (regional).

• Hyzaar (co-market legacy, Japan).

I

• Inavir — Laninamivir octanoate — Influenza treatment/prophylaxis — Single inhaled dose (40 mg).

• Iron formulations (Ferinject distribution in Japan).

• Iruvone — Loxoprofen sodium — Pain, inflammation — 60 mg TID.

J

• Jevtana (co-promotion in Japan) — Cabazitaxel.

• Jeysu (regional statin combo).

K

• Kaigen legacy OTC (Japan distribution).

• Kiklin — Calcium carbonate — Hyperphosphatemia in CKD — 500–1500 mg with meals.

• Kombiglyze XR (with AZ) — Saxagliptin + metformin.

L

• Lixiana — Edoxaban — see E.

• Loxonin — Loxoprofen sodium — Pain, inflammation — 60 mg TID.

• Loxonin Tape — Topical patch formulation.

• Loxonin Gel — Topical gel.

• Loxonin S — OTC oral form.

M

• Metogrel — Metoprolol (regional).

• Minolira (regional) — Minocycline — Acne.

• Motasol — Mosapride — Functional dyspepsia, GERD — 5 mg TID.

• Mucosolvan co-market (Japan).

N

• Nesina — Alogliptin — Type 2 diabetes — 25 mg QD.

• Nesina combo products:

  • Liovel — Alogliptin + pioglitazone.

  • Liomet XR — Alogliptin + metformin XR.

• Nexium co-marketed in Japan.

• Neoral distribution (Japan regional).

O

• Olmetec — Olmesartan — Hypertension — 20–40 mg QD.

• Olmetec Plus — Olmesartan + HCTZ.

• Olmesartan generics (global).

• Opalmon — Limaprost alfadex — Peripheral arterial disease — 5 mcg TID.

• Oroxine (Japan) — Levothyroxine.

P

• Pitava / Livalo — Pitavastatin — Hyperlipidemia — 1–4 mg QD.

• Prasugrel (Effient) — see E.

• Pradif T — Naftopidil + tadalafil — BPH + ED combo (Japan).

• Prandil — Repaglinide — T2DM — 0.5–4 mg TID pre-meal.

• Pletaal / Pletal — see C.

Q

• Quetiapine Daiichi — Quetiapine — CNS disorders.

• Quazepam Daiichi — Quazepam — Insomnia.

R

• Rezaltas — Olmesartan + amlodipine — Hypertension.

• Roxadustat (Japan approval, co-market) — Roxadustat — Anemia in CKD — 100 mg TIW oral.

• Rythmy — Disopyramide — Arrhythmia.

S

• Sevikar — Olmesartan + amlodipine — Hypertension.

• Sevikar HCT — Olmesartan + amlodipine + HCTZ.

• Sevikar OD — Oral disintegrating form (Japan).

• Syrup line (pediatric antibiotics, cough/cold generics).

T

• Tarlige — Mirogabalin — Peripheral neuropathic pain — 15–30 mg BID.

• Tavanic (Japan co-market) — Levofloxacin.

• Tenelia — Teneligliptin — T2DM — 20 mg QD.

• Trezenta (co-market with BI) — Linagliptin.

• Tribenzor — Olmesartan + amlodipine + HCTZ — Hypertension.

U

• Urief — Silodosin — BPH — 4–8 mg daily.

• Urate lowering pipeline.

V

• Vanflyta — Quizartinib — FLT3-ITD+ AML — 30–60 mg QD.

• Vesicare co-market Japan — Solifenacin.

• Valsartan Daiichi (generics).

• Vitamin line (Japan OTCs: Alinamin, etc.).

X

• Xarelto (co-market with Bayer) — Rivaroxaban.

• Xarvio (regional) — Plant health (non-human).

• Xatral Daiichi — Alfuzosin.

Y

• Yondelis (Japan distribution) — Trabectedin.

Z

• Zollipak — Fixed-dose antihypertensives (olmesartan + others).

• Zydena (Japan distribution regional) — Udenafil.